THE NICKLES GROUP, LLC

Lobbying for JAZZ PHARMACEUTICALS, INC. · Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing. Issues related to orphan drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.